Condition

Stage I Pancreatic Cancer

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions14

Lead sponsors shown2

Clinical trials

3 shown

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic CancerNCT01959672 · 2013-09-06

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerNCT00087191 · 2004-05-01

Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung CancerNCT00019006 · 1995-03-01

Common interventions

4-Dimensional Computed TomographyPROCEDURE1 Detox-B adjuvantDRUG1 EF5DRUG1 FluorouracilDRUG1 Gemcitabine HydrochlorideDRUG1 Laboratory Biomarker AnalysisOTHER1 Leucovorin CalciumDRUG1 motexafin lutetiumDRUG1 Nelfinavir MesylateDRUG1 OregovomabBIOLOGICAL1 pharmacological studyOTHER1 ras peptide cancer vaccineDRUG1 Stereotactic Body Radiation TherapyRADIATION1 Therapeutic Conventional SurgeryPROCEDURE1

Leading sponsors

National Cancer Institute (NCI)2 University of Nebraska1

Trial status mix

COMPLETED2

TERMINATED1

Phase mix

NA1

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.